Preliminary Study of sCD14 and sCD163 as Predictors of Disease Severity and ICU Admission in COVID-19: Relation to Hematological Parameters, Blood Morphological Changes and Inflammatory BiomarkersOriginal Article Published on 2023-09-012024-09-05 Journal: Journal of Heredity [Category] update2024, [키워드] blood count Blood morphology COVID-19 sCD14 sCD163 [DOI] 10.4084/MJHID.2023.046 PMC 바로가기 [Article Type] Original Article
Role of Tocilizumab in Down Regulating sCD163 Plasmatic Levels in a Cohort of COVID-19 PatientsCOVID-19 환자 집단에서 sCD163 혈장 수준을 하향 조절하는 토실리주맙의 역할Article Published on 2022-04-042022-09-12 Journal: Frontiers in Immunology [Category] 진단, [키워드] anti-IL-6 receptor Biomarker both group CD163 Cell Clinical outcome clinical utility Cohort comparable control group COVID-19 COVID-19 patient COVID-19 patients defined died discharge down-regulated early stage ELISA enrolled evaluated expressed Follow-up group groups healthy donor Hospital admission Hospitalization IL-6 Inflammatory involved Laboratory parameters lethality rate Level Lineage macrophages mechanical ventilation monoclonal antibody monocyte monocytes/macrophages outcome plasma Pneumonia pro-inflammatory proteolytic cleavage receptor reduce reduction in reductions in Regulating Regulation required role SARS-CoV-2 sCD163 severity of COVID-19 statistically stratified TCZ the disease Tocilizumab Treatment [DOI] 10.3389/fimmu.2022.871592 PMC 바로가기 [Article Type] Article
Up-regulated serum levels of soluble CD25 and soluble CD163 in pediatric patients with SARS-CoV-2SARS-CoV-2 소아 환자에서 가용성 CD25 및 가용성 CD163의 상향 조절된 혈청 수준Original Article Published on 2022-03-022022-09-11 Journal: European journal of pediatrics [Category] COVID19(2023년), MERS, SARS, 바이오마커, [키워드] age antagonist antagonists CD163 children Control COVID-19 cytokine Cytokine storm diagnostic biomarker Diagnostic biomarkers disease severity ELISA healthy control help hemophagocytic lymphohistiocytosis HLH host response Inflammatory initial Level marker MIS-C monitoring outcome Patient patients with COVID-19 patients with SARS-CoV-2 Pediatric patient presenting pro-inflammatory receptor SARS-CoV-2 SARS-CoV-2 patient SARS-CoV-2 patients sCD163 sCD25 serum Serum level severity significant decrease significantly higher soluble CD25 syndrome the disease the healthy therapeutic Treatment up-regulated were measured [DOI] 10.1007/s00431-022-04398-8 PMC 바로가기 [Article Type] Original Article
Increased Serum Levels of sCD14 and sCD163 Indicate a Preponderant Role for Monocytes in COVID-19 ImmunopathologyImmunology Published on 2020-09-232022-11-01 Journal: Frontiers in Immunology [Category] COVID-19, MERS, SARS, [키워드] Activation Admission analyzed association control group correlation corticoid COVID-19 COVID-19 patients disease ELISA Evidence healthy control Hospital admission hospitalized patients Hydroxychloroquine ICU ICU admission immunopathology Increased indicate Infection Inflammatory marker inflammatory markers investigated knowledge Laboratory parameters Level marker moderate monocyte Monocyte activation monocyte-macrophage non-ICU non-ICU patient positive positive correlation recruited Result role sCD14 sCD163 severity significantly higher Tocilizumab [DOI] 10.3389/fimmu.2020.560381 PMC 바로가기 [Article Type] Immunology
Plasma levels of eight different mediators and their potential as biomarkers of various clinical malaria conditions in African children아프리카 어린이의 다양한 임상 말라리아 상태에서 여덟 가지 서로 다른 매개체의 혈장 수준과 그들의 바이오마커로서의 잠재력Research Published on 2016-06-292024-08-12 Journal: Malaria Journal [Category] 말라리아, [키워드] Biomarkers cerebral malaria fractalkine Neopterin Plasmodium falciparum sCD14 sCD163 sTREM-1 suPAR [DOI] 10.1186/s12936-016-1378-3 PMC 바로가기 [Article Type] Research
Haptoglobin phenotype prevalence and cytokine profiles during Plasmodium falciparum infection in Dogon and Fulani ethnic groups living in Mali말리에서 거주하는 도곤족과 풀라니족의 Plasmodium falciparum 감염 중 헤모글로빈 결합 단백질 표현형 유병률 및 사이토카인 프로필Research Published on 2013-11-252024-08-13 Journal: Malaria Journal [Category] 말라리아, [키워드] Cytokines Dogon Fulani Haptoglobin phenotypes Mali Plasmodium falciparum sCD163 [DOI] 10.1186/1475-2875-12-432 PMC 바로가기 [Article Type] Research